News

September 15th, 2018

MEBIAS Discovery Receives Grant from NIDA to Advance Its Signaling-Pathway Selective Mu-Opioid Receptor Drug Candidate

April 4th, 2018

NIH launches HEAL Initiative, doubles funding to accelerate scientific solutions to stem national opioid epidemic

December 5th, 2017

‘Biased’ opioids could yield safer pain relief

New compounds activate opioid receptor in a way that protects breathing

October 19th, 2017

Mebias’ mu opioids best morphine, Trevena drug in preclinical studies

October 16th, 2017

MEBIAS Discovery LLC Presents Pre-Clinical Data on Mu Opioid Receptor Pain Compounds at ADDC